ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31

AC Immune SA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026

$2.44+0.04 (+1.88%)

Close on Oct 19, 2026

AC Immune SA revenue by segment

Annual Quarterly TTM

By business segment

By product or service

By region

From the segment and revenue-disaggregation notes of AC Immune's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.